Walter Pearcy
Cardiovascular Disease · Morganton, NCNPI 1003873530
Payments from drug & device makers
Across 196 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$670
- Novartis$390
- Amgen$348
- Johnson & Johnson$275
- E.r. Squibb & Sons, L.L.C.$269
- Boehringer Ingelheim$245
- plus $797 from 16 others
What the payments were for
- Food & beverage$2,96599%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 48 | $670 |
| Novartis | 25 | $390 |
| Amgen | 24 | $348 |
| Johnson & Johnson | 21 | $275 |
| E.r. Squibb & Sons, L.L.C. | 17 | $269 |
| Boehringer Ingelheim | 14 | $245 |
| Merck | 12 | $214 |
| AstraZeneca | 9 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $80 |
| Lexicon Pharmaceuticals, Inc. | 4 | $72 |
| Boston Scientific | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $30 |
| Edwards Lifesciences | 2 | $28 |
| Cordis US CORP. | 1 | $24 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Atricure, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Quidel Corporation | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Novo Nordisk | 1 | $13 |
How this compares
$2,994 in reported general payments places this provider in the 50th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $41,778 |
| JardianceEmpagliflozin | 11 | $6,516 |
| Metoprolol Succinate | 47 | $711 |
| Atorvastatin Calcium | 39 | $393 |
| Spironolactone | 16 | $160 |
| Rosuvastatin Calcium | 11 | $125 |
| Carvedilol | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $670 | $41,77849 claims |
| Boehringer IngelheimJardiance | $245 | $6,51611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 727 cardiovascular disease providers in North Carolina.
Other cardiovascular disease in Morganton
- Sean PokorneyMorganton$1.1M
- Steven IssermanMorganton$787K
- John AlexanderDurham$76.8M
- Christopher GrangerDurham$24.7M
- Jonathan PicciniDurham$14.3M
- Adrian HernandezDurham$13.2M
- Gary FelkerDurham$12.7M
- Robert MentzDurham$6M
- Michael ShapiroWinston-Salem$5.4M
- Kirkwood AdamsChapel Hill$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.